Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy

被引：3
|
作者：
Jacques, S. K. [1 ]
McKeown, J. [2 ]
Grover, P. [3 ]
Park, B. [4 ]
Zaremba, A. [5 ]
Dimitriou, F. [6 ]
Rashid, M. F. Harunal [7 ]
Namikawa, K. [8 ]
Mooradian, M. [9 ]
Placzke, J. [10 ]
Allayous, C. [11 ]
Mehmi, I. [12 ]
DePalo, D. [13 ]
Wicky, A. [14 ]
Schwarze, J. K. [15 ]
Nakamura, Y. [16 ]
Benannoune, N. [17 ]
Menzies, A. M. [18 ]
Lo, S. N. [19 ]
Carlino, M. S. [1 ]
机构：
[1] Crown Princess Mary Canc Ctr Westmead, Med Oncol Dept, Westmead, NSW, Australia
[2] Melanoma Inst Australia, Biostat, Wollstonecraft, NSW, Australia
[3] Melanoma Inst Australia, Med Oncol, Wollstonecraft, NSW, Australia
[4] Vanderbilt Univ, Med Ctr, Med Oncol, Nashville, TN USA
[5] Univ Klinikum Essen, Dermatol, Essen, Germany
[6] USZ Univ Zurich Hosp, Dermatol Dept, Zurich, Switzerland
[7] NCCS Natl Canc Ctr Singapore, Med Oncol Dept, Singapore, Singapore
[8] NCCH Natl Canc Ctr Hosp, Dermatol Oncol Dept, Chuo Ku, Tokyo, Japan
[9] Massachusetts Gen Hosp, Ctr Canc, Oncol, Boston, MA USA
[10] Maria Sklodowska Curie Natl Res Inst Oncol, Soft Tissue & Bone Sarcoma & Melanoma Clin, Warsaw, Poland
[11] Hop St Louis, AP HP, Med Oncol, Paris, France
[12] Angeles Clin & Res Inst, Med Oncol, Santa Monica, CA USA
[13] H Lee Moffitt Canc Ctr & Res Inst, Med Oncol, Magnolia Campus, Tampa, FL USA
[14] CHUV Ctr Hosp Univ Vaudois, Oncol Dept, Batiment Agora, Lausanne, Switzerland
[15] Univ Ziekenhuis Brussel, Med Oncol, Jette, Belgium
[16] Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, Hidaka, Japan
[17] Gustave Roussy, Med Oncol, Canc Campus, Villejuif, France
[18] Melanoma Inst Australia, Med Oncol Dept, Suite 5-6, Wollstonecraft, NSW, Australia
[19] Univ Sydney, Sch Publ Hlth, Melanoma Inst Australia, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.935
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
809P
引用
收藏
页码：S915 / S916
页数：2
相关论文
共 50 条
  • [1] Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
    Jacques, Sarah K.
    McKeown, Janet
    Grover, Piyush
    Johson, Douglas B.
    Zaremba, Anne
    Dimitriou, Florentia
    Weiser, Roi
    Farid, Mohamad
    Namikawa, Kenjiro
    Sullivan, Ryan J.
    Rutkowski, Piotr
    Lebbe, Celeste
    Hamid, Omid
    Zager, Jonathan S.
    Michielin, Olivier
    Neyns, Bart
    Nakamura, Yasuhiro
    Robert, Caroline
    Mehnert, Janice
    Ascierto, Paolo A.
    Bhave, Prachi
    Park, Benjamin
    Zimmer, Lisa
    Mangana, Joanna
    Mooradian, Megan
    Placzke, Joanna
    Allayous, Clare
    Oliva, Isabella C. Glitza
    Mehmi, Inderjit
    Depalo, Danielle
    Wicky, Alexandre
    Schwarze, Julia K.
    Roy, Severine
    Boatwright, Christina
    Vanella, Vito
    Long, Georgina, V
    Menzies, Alexander M.
    Lo, Serigne N.
    Carlino, Matteo S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 199
  • [2] The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
    Arak, Haci
    Erkilic, Suna
    Yaslikaya, Sendag
    Mocan, Eda Eylemer
    Aktas, Gokmen
    Ozdemir, Melek
    Semiz, Huseyin Salih
    Kilickap, Saadettin
    Ozalp, Faruk Recep
    Sever, Ozlem Nuray
    Akdag, Goncagul
    Agaoglu, Ahmet Burak
    Ozcelik, Melike
    Sari, Murat
    Arcagok, Murat
    Anik, Hicran
    Yayla, Saziye Burcak
    Sever, Nadiye
    Acar, Fatma Pinar
    Bayrakci, Ismail
    Turhal, Serdar
    Ayhan, Murat
    Kus, Tulay
    [J]. JOURNAL OF IMMUNOTHERAPY, 2024, 47 (05) : 182 - 189
  • [3] Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma
    Roccuzzo, Gabriele
    Fava, Paolo
    Astrua, Chiara
    Brizio, Matteo Giovanni
    Cavaliere, Giovanni
    Bongiovanni, Eleonora
    Santaniello, Umberto
    Carpentieri, Giulia
    Cangiolosi, Luca
    Brondino, Camilla
    Pala, Valentina
    Ribero, Simone
    Quaglino, Pietro
    [J]. CANCERS, 2024, 16 (17)
  • [4] Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy
    Egeler, Mees
    Lai-Kwon, Julia
    Tissier, Renaud
    Fraterman, Itske
    Kuijpers, Anke
    Van Houdt, Winan
    Wilgenhof, Sofie
    Rao, Aparna
    Sandhu, Shahneen
    Lee, Rebecca
    Eriksson, Hanna
    van Leeuwen, Marieke
    de Ligt, Kelly
    van Akkooi, Alexander
    van de Poll-Franse, Lonneke
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 200
  • [5] The Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma
    Shoushtari, Alexander N.
    Munhoz, Rodrigo R.
    Kuk, Deborah
    Ott, Patrick A.
    Johnson, Douglas B.
    Tsai, Katy K.
    Rapisuwon, Suthee
    Eroglu, Zeynep
    Sullivan, Ryan J.
    Luke, Jason J.
    Gangadhar, Tara C.
    Salama, April K. S.
    Clark, Varina
    Burias, Clare
    Puzanov, Igor
    Atkins, Michael B.
    Algazi, Alain P.
    Ribas, Antoni
    Wolchok, Jedd D.
    Postow, Michael A.
    [J]. CANCER, 2016, 122 (21) : 3354 - 3362
  • [6] Adjuvant treatment with anti-PD-1 in acral melanoma patients: A nationwide study
    Bloem, M.
    van Not, O. J.
    Haanen, J. B. A. G.
    Blank, C. U.
    Aarts, M. J. B.
    Van den Berkmortel, F. W. P. J.
    de Groot, J. W.
    Hospers, G. A. P.
    Kapiteijn, E.
    Piersma, D.
    van Rijn, R. S.
    Boer, M. Stevense-den
    Van der Veldt, A. A. M.
    Vreugdenhil, G.
    Bonenkamp, H.
    Boers-Sonderen, M. J.
    Blokx, W. A.
    Van Den Eertwegh, F.
    Suijkerbuijk, K. P. M.
    Wouters, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S658 - S658
  • [7] Temozolomide plus cisplatin versus toripalimab (anti-PD-1) as adjuvant therapy in resected mucosal melanoma.
    Lian, Bin
    Tian, Hui
    Si, Lu
    Chi, Zhihong
    Sheng, Xinan
    Wang, Xuan
    Mao, Lili
    Bai, Xue
    Tang, Bixia
    Yan, Xieqiao
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Cui, Chuanliang
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Delayed and persistent multisystem toxicities of adjuvant anti-PD-1 therapy for stage III melanoma
    Goodman, Rachel S.
    Justice, Joy
    Gardner, Laura J.
    Singh, Reena
    Dewan, Anna K.
    Johnson, Douglas B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 192
  • [9] Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study
    Bloem, Manja
    van Not, Olivier J.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Blokx, Willeke A. M.
    Boers-Sonderen, Marye J.
    Bonenkamp, Johannes J.
    de Groot, Jan-Willem B.
    Haanen, John B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen W.
    de Meza, Melissa M.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion A. M.
    van Der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    van den Eertwegh, Alfons J. M.
    Suijkerbuijk, Karijn P. M.
    Wouters, Michel W. J. M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (08) : 1455 - 1465
  • [10] Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients
    Di Pietro, Francesca Romana
    Verkhovskaia, Sofia
    Falcone, Rosa
    Poti, Giulia
    Carbone, Maria Luigia
    Morelli, Maria Francesca
    Zappala, Albina Rita
    Morese, Roberto
    Di Rocco, Zorika Christiana
    Piesco, Gabriele
    Chesi, Paolo
    Failla, Cristina Maria
    Marchetti, Paolo
    De Galitiis, Federica
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
12345